Kumar SR - Search Results

1

Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy.

Deutscher SL, Dickerson M, Gui G, Newton J, Holm JE, Vogeltanz-Holm N, Kliethermes B, Hewett JE, Kumar SR, Quinn TP, Sauter ER. Deutscher SL, et al. Among authors: kumar sr. BMC Cancer. 2010 Oct 1;10:519. doi: 10.1186/1471-2407-10-519. BMC Cancer. 2010. PMID: 20920311 Free PMC article.

2

Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.

Kumar SR, Sauter ER, Quinn TP, Deutscher SL. Kumar SR, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6868-71. doi: 10.1158/1078-0432.CCR-05-0146. Clin Cancer Res. 2005. PMID: 16203776

3

Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas.

Kumar SR, Quinn TP, Deutscher SL. Kumar SR, et al. Clin Cancer Res. 2007 Oct 15;13(20):6070-9. doi: 10.1158/1078-0432.CCR-07-0160. Clin Cancer Res. 2007. PMID: 17947470

4

111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.

Kumar SR, Deutscher SL. Kumar SR, et al. J Nucl Med. 2008 May;49(5):796-803. doi: 10.2967/jnumed.107.048751. Epub 2008 Apr 15. J Nucl Med. 2008. PMID: 18413389 Free article.

5

In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL. Kumar SR, et al. Cancer Biother Radiopharm. 2010 Dec;25(6):693-703. doi: 10.1089/cbr.2010.0820. Cancer Biother Radiopharm. 2010. PMID: 21204764 Free PMC article.

6

(64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.

Kumar SR, Gallazzi FA, Quinn TP, Deutscher SL. Kumar SR, et al. J Nucl Med. 2011 Nov;52(11):1819-26. doi: 10.2967/jnumed.111.093716. Epub 2011 Oct 7. J Nucl Med. 2011. PMID: 21984800 Free article.

7

Tumor targeting and SPECT imaging properties of an (111)In-labeled galectin-3 binding peptide in prostate carcinoma.

Deutscher SL, Figueroa SD, Kumar SR. Deutscher SL, et al. Among authors: kumar sr. Nucl Med Biol. 2009 Feb;36(2):137-46. doi: 10.1016/j.nucmedbio.2008.10.015. Nucl Med Biol. 2009. PMID: 19217525

8

In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas.

Deutscher SL, Figueroa SD, Kumar SR. Deutscher SL, et al. Among authors: kumar sr. J Labelled Comp Radiopharm. 2009 Dec 1;52(14):583-590. doi: 10.1002/jlcr.1691. J Labelled Comp Radiopharm. 2009. PMID: 20976123 Free PMC article.

9

In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.

Newton-Northup JR, Dickerson MT, Kumar SR, Smith GP, Quinn TP, Deutscher SL. Newton-Northup JR, et al. Among authors: kumar sr. Mol Imaging Biol. 2014 Dec;16(6):854-64. doi: 10.1007/s11307-014-0762-z. Mol Imaging Biol. 2014. PMID: 25001195

10

Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.

Kumar SR, Bryan JN, Esebua M, Amos-Landgraf J, May TJ. Kumar SR, et al. BMC Cancer. 2017 Feb 24;17(1):158. doi: 10.1186/s12885-017-3134-7. BMC Cancer. 2017. PMID: 28235398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters